Laguyon, Nor-ain O.
HRN: 23-60-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2023
CEFUROXIME 500MG (TAB)
08/30/2023
09/06/2023
PO
500mg
BID X 7 Days
S/P NSVD With RMLE And Repair; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes